Innovative Medicine
-
U.S. FDA Grants Priority Review for XARELTO® (rivaroxaban) Supplemental NDAs for the Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and the Long-Term Prevention of Recurrent DVT and PE
Company Also Provides Update on Stent Thrombosis sNDA -
-
-
VELCADE® Receives Positive Regulatory Recommendation in the European Union for Subcutaneous Administration
New route of administration provides improved safety and greater convenience for patients and healthcare professionals -
-
-
Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
Collaboration between researchers led to major impact on understanding gene regulation -
Janssen Submits Additional Marketing Applications for ZYTIGA® In the U.S. and European Union
Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study -
Positive Results from First Human Clinical Trials of a First-Generation Artificial Pancreas System is Significant Step Forward for Millions with Type 1 Diabetes
System in Development from Animas-JDRF Partnership Successfully Detects Highs and Lows, and Shown to Safely and Automatically Adjust Insulin Delivery in Clinical Setting